Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novelion Therapeutics Inc (NASDAQ:NVLN)

1.80
Delayed Data
As of Dec 06
 -0.06 / -3.23%
Today’s Change
1.22
Today|||52-Week Range
2.76
-8.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization1.2M964.0K891.0K576.0K
 
 
 
 
 
 
Operating ExpensesGross Income-1.2M-964.0K-891.0K-576.0K
 
 
 
 
 
General Expenses39.7M25.5M20.4M16.0M
 
 
 
 
 
Research And Development24.6M18.5M13.8M9.8M
 
 
 
 
 
Total Operating Expenses40.8M26.5M21.3M16.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-40.8M-26.5M-21.3M-16.6M
 
 
 
 
 
Extraordinary Credit8.2M2.9M17.5M0.00
 
 
 
 
Extraordinary Charge-13.9M-2.0M-534.0K-6.7M
 
 
 
 
 
Other Expenses52.0K175.0K53.0K81.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-46.2M-25.2M-4.2M-23.0M
 
 
 
 
 
Income Taxes-3.9M-599.0K-192.0K-22.0K
 
 
 
 
 
Discontinued Operations88.0M967.0K-66.0K0.00
 
 
 
 
Net Income45.7M-24.9M-4.1M-23.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.1M50.9M51.1M52.2M
 
 
 
 
 
Shares To Calculate EPS Diluted50.1M50.9M51.1M52.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.91-$0.49-$0.08-$0.44
 
 
 
 
 
EPS Diluted$0.91-$0.49-$0.08-$0.44